Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335230 · ClinicalTrials.gov registry record
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 40
- Enrollment target
NCT01335230: Completed study, sponsored by University of Cincinnati.
NCT01335230 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01335230 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this research study is to explore what role immune cells within the gut (the sigmoid colon) have locally and on the immune system of patients infected with HCV, HIV or HCV/ HIV co-infection.
Primary Outcome
We measure gene transcription of the colon tissues (relative expression fold changes of gene transcription compared to control). No preselected criteria were used to assess the participants. Data were analyzed and compared among each group. Relative expression levels of LEAP-2 (Liver expressed anti-microbial peptide-2) in the four groups were shown in the table below. Detailed of other genes had been published in Shata MT, et al, J. Clin Pathology 2013, Nov 66(11):967-75. PMID 23940131, and Abde
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-01 |
What the finished NCT01335230 record still lists
NCT01335230 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01335230 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01335230 about?
NCT01335230 is a clinical study titled "The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients". The purpose of this research study is to explore what role immune cells within the gut (the sigmoid colon) have locally and on the immune system of patients infected with HCV, HIV or HCV/ HIV co-infection.
What is the current status of trial NCT01335230?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2011-04. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT01335230?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia